Laboratorios Almirall, S.A.

Espagne

 
Quantité totale PI 18
Rang # Quantité totale PI 83 143
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 656 821

Brevets

Marques

1 0
0 0
17 0
0
 
Dernier brevet 2012 - Derivatives of 4-(2-amino-1-hydr...
Premier brevet 1990 - New xanthine derivatives

Filiales

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2011 Invention Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor. The...
2008 Invention Combinations comprising antimuscarinic agents and pde4 inhibitors. A combination which comprises...
Invention Quinuclidine amide derivatives. New quinuclidine amide derivatives having the chemical structure ...
2007 Invention Inhalation device for drugs in powder form. To provide an inhalation device which has improved us...
Invention Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors. A compound of formula (I) ...
Invention Substituted pyrimidines as adenosine receptor antagonists. Compounds of formula (I) including pha...
Invention 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b aden...
Invention Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor. Th...
Invention Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor. T...
Invention Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor. T...
Invention 1,7-naphthyridine derivatives as p38 map kinase inhibitors. New inhibitors of the p38 mitogen-act...
Invention 1, 7-naphthyridine derivatives as p38 map kinase inhibitors. This invention is directed to new in...
Invention Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabi...
Invention Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor. This ...
Invention Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the &bgr;2 adrenergic receptor. Th...
Invention New pyridin-3-amine derivatives. This invention is directed to new inhibitors of the p38 mitogen...
Invention New pyridin-3-amine derivatives. This invention is directed to new inhibitors of the p38 mitogen-...
Invention Phenoxy-substituted pyrimidines as adenosine receptor antagonists. Compounds of formula (I), incl...
Invention New pyrrolidinium derivatives. New pyrrolidinium derivatives having the chemical structure of g...
2006 Invention 2b adenosine receptor antagonists. The present disclosure relates to imidazopyridine derivatives ...
Invention Imidazopyridine derivatives as a2b adenosine receptor antagonists. New imidazopyrdidine derivativ...
Invention Pyrazine derivatives useful as adenosine receptor antagonists. The present disclosure relates to ...
Invention Pyrazine derivatives useful as adenosine receptor antagonists. The present invention provides a c...
Invention Pyrido[3' ,2':4,5]furo[3,2-d]pyrimidine derivatives. The present disclosure relates to a pyridof...
Invention New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives. The present invention provides a pyridofu...
Invention New pyrido⏧3',2':4,5]furo⏧3,2-d]pyrimidine derivatives. The present invention...
Invention Tablets with improved dissolution profile. The present disclosure relates to tablets obtainable ...
Invention Tablets with improved dissolution profile. The invention relates to tablets obtainable by compres...
Invention N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists. New antagonists of the i...
Invention N-amide derivatives of 8-azabicyclo⏧3.2.1]oct-3-yl as ccr1 antagonists. The present inventio...
Invention Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the &bgr;2 adrenergic receptor. Th...
Invention Combinations comprising antimuscarinic agents and beta-adrenergic agonists. Combinations compris...
Invention Combinations comprising antimuscarinic agents and corticosteroids. Combinations comprising (a) a...
Invention 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists. Compounds of formul...
2005 Invention Process for preparing quinuclidinium carbamate derivatives. A new process for preparing carbamat...
Invention Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors. The invention relates to new t...
Invention H)-one derivatives and their use as pde4 inhibitors. The invention relates to new therapeutically...
Invention Combinations comprising antimuscarinic agents and corticosteroids. The present invention provid...
Invention Combinations comprising antimuscarinic agents and beta-adrenergic agonists. The present inventi...
Invention Condensed pyridine derivatives useful as a2b adenosine receptor antagonists. New antagonists of ...
Invention Quaternized quinuclidine esters. Compounds of formula (I) Compounds of formula (I) ...
2004 Invention Non-tabletted, chewable, individually dosed administration forms. Non-tabletted, individually do...
Invention Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors. New pyridazin-e-(2H)-one deriva...
Invention Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists. This inventio...
Invention 2,3'-bipyridines derivatives as selective cox-2 inhibitors. The present invention relates to 2,...
Invention 3-phenylfuran-2-one derivatives as cox-2 inhibitor. The present invention relates to 3-phenylfu...
Invention 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as pde7 inhibitors. New 4-aminothieno[2...